MOLECULARMD
MolecularMD Corporation develops and commercializes specialty molecular diagnostics for oncology applications. Its tests are designed to allow appropriate selection, monitoring and management of patients treated with molecularly targeted cancer therapies. MolecularMD’s assays incorporate both gold-standard and innovative technologies to provide highly sensitive, standardized, reliable results that support clinical development, regulatory approval, and commercialization of novel anticancer agents. A private company based in Portland, Oregon, MolecularMD was founded by Brian Druker, director of the Knight Cancer Center at Oregon Health & Science University, and Sheridan G. Snyder, entrepreneur and founder of Genzyme Corporation and Upstate Biotechnology.
MOLECULARMD
Social Links:
Industry:
Biotechnology Health Diagnostics Medical Pharmaceutical
Founded:
2005-01-01
Address:
Portland, Oregon, United States
Country:
United States
Website Url:
http://www.molecularmd.com
Total Employee:
101+
Status:
Active
Contact:
1(877)459-4979
Email Addresses:
[email protected]
Total Funding:
14 M USD
Technology used in webpage:
SPF LetsEncrypt IPv6 Microsoft Azure DNS Cloudflare Hosting Cloudflare DNS DMARC Unified Layer Mimecast WebEx
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Biosite Incorporated
Biosite Incorporated provides diagnostic products and antibody development technologies for sever diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Galena Biopharma
Galena Biopharma, Inc. is focused on discovering, developing and commercializing innovative therapies.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Roche Molecular Systems
Roche Molecular Systems, Inc., a molecular diagnostics company, develops and commercializes diagnostic and blood screening tests based on
Current Advisors List
Current Employees Featured
Founder
Investors List
Ballast Point Ventures
Ballast Point Ventures investment in Series B - MolecularMD
Nextech Invest
Nextech Invest investment in Series B - MolecularMD
Ballast Point Ventures
Ballast Point Ventures investment in Series A - MolecularMD
Newest Events participated
Official Site Inspections
http://www.molecularmd.com
- Host name: 104.18.20.41
- IP address: 104.18.20.41
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "MolecularMD"
MolecularMD - Crunchbase Company Profile & Funding
MolecularMD Corporation develops and commercializes specialty molecular diagnostics for oncology applications. Its tests are designed to allow appropriate selection, monitoring and management of patients treated with molecularly …See details»
Acquisition of MolecularMD | Laboratories - ICON plc
Feb 21, 2019 · MolecularMD integrates gold standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, …See details»
MolecularMD Company Profile 2024: Valuation, Investors
Developer of molecular diagnostic technology designed to accelerate oncology drug approval.See details»
Cancer startup: Drug development company acquires …
Mar 27, 2019 · The clinical research organization ICON, based in Dublin, Ireland, has acquired MolecularMD, a molecular diagnostic specialty lab that focuses on the development and commercialization of precision medicines for oncology.See details»
MolecularMD Corp. Company Profile | Portland, OR | Competitors ...
Find company research, competitor information, contact details & financial data for MolecularMD Corp. of Portland, OR. Get the latest business insights from Dun & Bradstreet.See details»
MolecularMD is acquired by ICON - GlobeNewswire
Feb 21, 2019 · PORTLAND, Ore. and CAMBRIDGE, Mass., Feb. 21, 2019 (GLOBE NEWSWIRE) -- MolecularMD Corporation, a molecular diagnostic specialty laboratory that enables the …See details»
MolecularMD - Products, Competitors, Financials, Employees ...
Feb 28, 2019 · MolecularMD is a provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers.See details»
Irish CRO ICON Acquires MolecularMD
Feb 21, 2019 · Pharmaceutical, biotech, and medical device contract research organization (CRO) ICON, based in Dublin, Ireland announced in its year-end earnings statement that it …See details»
MolecularMD is Acquired by ICON | Pharmaceutical Outsourcing
Feb 21, 2019 · MolecularMD, a molecular diagnostic specialty laboratory that enables the development and commercialization of precision medicines in oncology, has been acquired by …See details»
ICON acquires MolecularMD - 2019-02-21 - Crunchbase
Feb 21, 2019 · MolecularMD MolecularMD provides molecular diagnostics products and services to support clinical development and commercialization of cancer therapies. Acquiring …See details»
MolecularMD - VentureRadar
"MolecularMD is a vertically integrated molecular diagnostics company focusing on oncology. Founded in 2005, it provides molecular testing to enable clinical decisions for the use of the …See details»
MolecularMD Is Acquired By ICON - drugdiscoveryonline.com
MolecularMD Corporation, a molecular diagnostic specialty laboratory that enables the development and commercialisation of precision medicines in oncology, announced today that …See details»
Icon Acquires MolecularMD - GenomeWeb
Feb 21, 2019 · MolecularMD is expected to expand Icon's laboratory services by enabling it to better support precision medicine programs for drug-diagnostic codevelopment.See details»
ICON Acquires MolecularMD For Cancer Research Tech - Seeking …
Feb 25, 2019 · MolecularMD [MMD] has developed a full service diagnostics service line to accelerate oncology (cancer) drug approval. With the deal for MMD, ICLR gains increased …See details»
MolecularMD - Contacts, Employees, Board Members, Advisors
MolecularMD provides molecular diagnostics products and services to support clinical development and commercialization of cancer therapies.See details»
Molecular MD | Scientist.com
MolecularMD (MMD) streamlines the co-development and commercialization of molecular diagnostic tests that are deployed and leveraged across the continuum of the drug …See details»
Icon snaps up molecular Dx specialist MolecularMD for …
Feb 28, 2019 · Icon, a CRO based in Dublin, has acquired MolecularMD, a molecular diagnostic specialty lab that focuses on a platform for the development and commercialization of …See details»
MolecularMD Corporate Overview - YouTube
Watch this overview video to learn how MolecularMD develops and commercializes specialty molecular diagnostics for oncology applications.See details»
MolecularMD Closes $6 Million Series B Financing and ... - BioSpace
MolecularMD Corporation develops and commercializes specialty molecular diagnostics for oncology applications. Its tests are designed to allow appropriate selection, monitoring and …See details»
MolecularMD achieves status as an ArcherDX Certified Service …
Jun 1, 2017 · MolecularMD Corp., a molecular diagnostics company that provides clinical trial services and development of companion diagnostics for targeted and immunotherapies in …See details»